"10.1371_journal.pone.0101672","plos one","2014-07-14T00:00:00Z","Ameneh Khatami; Elizabeth A Clutterbuck; Amber J Thompson; Jennifer A McKenna; David Pace; Jacqueline Birks; Matthew D Snape; Andrew J Pollard","Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom; Malta Children's Vaccine Group, Mater Dei Hospital, Tal-Qroqq, Msida, Malta; Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom","Conceived and designed the experiments: AK EAC DP MDS AJP. Performed the experiments: AK EAC AJT JAM. Analyzed the data: AK JB. Wrote the paper: AK EAC AJT JAM DP JB MDS AJP.","This study has received part-funding from a commercial source. Funding was received from GlaxoSmithKline Biologicals, Rixensart, Belgium. AJP and MDS act as chief or principal investigators for clinical trials conducted by the University of Oxford, sponsored by vaccine manufacturers, but receive no personal payments from them. MDS has participated in advisory boards and industry sponsored symposium for vaccine manufacturers, but receives no personal payments for this work. AK and MDS have received financial assistance from vaccine manufacturers to attend conferences. One of the vaccines included in the study [Hib-MenC-TT (MenitorixTM, GlaxoSmithKline Biologicals, Rixensart, Belgium)] is produced by GlaxoSmithKline. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials and the authors have no competing interests with respect to the findings of this report.",NA,NA,NA,"2014","07","Ameneh Khatami","AK",8,FALSE,5,4,2,8,TRUE,TRUE,FALSE,0,NA,FALSE
